Article
Gene expression changes in response to E2F1 activation
15 Apr 2002
Abstract excerpt
The p16/RB/E2F regulatory pathway, which controls transit through the G1 restriction point of the cell cycle, is one of the most frequent targets of genetic alterations in human cancer. Any of these alterations results in the deregulated expression of the transcription factor E2F, one of the key mediators of cell cycle progression. Under these conditions, E2F1 also participates in the induction of apoptosis by a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
